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as well as HMW proteins that cross-reacted with anti-NGAL and
anti-MMP-9 antibodies but not with the anti-MMP-13 antibody.
In addition, anti-NGAL antibody or anti-MMP-9 antibody, but not
anti-MMP-13 antibody, was able to specifically immunoprecipi-
tate the ∼130-kDa HMW synovial fluid MMP activity. Conditioned
media from chondrocytes stimulated with IL-1β also showed el-
evated levels of the MMP-9/NGAL complex and MMP-9 activity,
detected by Western immunoblotting and enzymography, re-
spectively. Additional studies showed that the HMW synovial
fluid MMP-9 activity co-migrated with a purified MMP-9/NGAL
complex on a gelatin zymogram. Furthermore, the MMP-9/NGAL
complex could be reconstituted in vitro by mixing recombinant
human MMP-9 and NGAL in gelatinase assay buffer. The ex-
pression of MMP-9 and NGAL mRNA was enhanced several fold
in IL-1β-treated human OA chondrocytes. Conditioned medium
of human chondrocytes transfected with either NGAL or MMP-9
siRNA showed significantly lower MMP-9/NGAL complex levels
when compared to chondrocytes cultures transfected with MMP-
13 siRNA (P<0.05). Recombinant human MMP-9 incubated in
gelatinase assay buffer in the absence of NGAL showed rapid
MMP-9 degradation with loss of MMP-9 activity. Histochemical
and biochemical analysis of human cartilage explants showed
that proteoglycan and Type II collagen content loss was signifi-
cantly elevated when NGAL was added exogenously to human
cartilage explant cultures stimulated with IL-1β (p <0.05).
Conclusions: IL-1β-stimulated human chondrocytes expressed
NGAL and MMP-9 which combined to form a HMW active MMP-
9/NGAL complex. These results showed that the MMP-9/NGAL
complex protected MMP-9 from auto-degradation since a rapid
loss of MMP-9 activity was detected in the absence of NGAL.
These results suggested that NGAL inhibition may be a useful
therapeutic approach for suppressing cartilage degradation in
OA.
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Purpose: Activation of toll-like receptors (TLR) by endogenous
ligands has been suggested as a mechanism for response to
tissue damage. Both TLR-2 and TLR-4 have been implicated
in this process. Our recent work has suggested that expression
of the chitinase 3-like protein (Chi3L) 1 in rat chondrocytes
is controlled mainly by the NF-kappa B signalling pathway, a
major component of the toll-like receptor (TLR) signalling system,
suggesting that its production could be part of the cells’ response
to activation of TLRs. In contrast to rodent chondrocytes, human
cells express two forms of Chi3L proteins, designated 1 and 2.
The aim of the work reported below was to investigate whether
expression of both Chi3L proteins in articular chondrocytes was
part of the TLR-response in these cells and whether or not their
expression was co-ordinated in human cartilage.
Methods: Articular chondrocytes were isolated from femoral
heads of neonatal rats and used in primary cultures. Human
articular chondrocytes were isolated from cartilage harvested
from the femoral condyles and tibial plateaus of a juvenile donor.
Frozen stocks at passage levels 3 to 5 were used for this
study. Confluent monolayers were stimulated with TNF-alpha, IL-
1, lipopolysaccharide (LPS) or peptidoglycan (PGN). Production
of Chi3L1 and 2 was analysed in culture media after 24 or
48 h of exposure, using western blotting and specific antisera
recognizing the C-terminal peptides of rat or human Chi3L1 or
human Chi3L2. Cellular RNA was isolated from the cell-layers
and analysed by RT-PCR for mRNA levels of Chi3L1 and 2 as
well as for TLR type expression.
Results: Rat chondrocytes exposed to LPS produced large
quantities of Chi3L1, suggesting that its induction is a major com-
ponent of the TLR-4 response repertoire. Stimulation of intact rat
femoral heads resulted in a similar, strong induction of Chi3L1.
Analysis of RNA preparations from rat chondrocytes by RT-PCR
suggested that TLR-4 was the predominant receptor form.
In contrast to Chi3L1, Chi3L2 was not detectable in unstimulated
human chondrocytes. However, strong induction of Chi3L2 was
observed in cultures exposed to TNF-alpha or Il-1, suggesting a
similar regulatory process as described for rat Chi3L1. The most
potent induction was observed on exposure of the chondrocytes
to PGN, while LPS had only a mild stimulatory effect, suggesting
that in human articular chondrocytes, TLR-2 is the major form of
the receptor. Analysis of mRNA levels also indicated that TLR2
may be the major receptor expressed in these cells. Production of
Chi3L1 was also increased significantly following the addition of
inflammatory mediators. As for Chi3L2, activation of TLR-2, using
PGN, was more effective than activation of TLR-4, using LPS.
Conclusions: The expression of both the Chi3L1 and Chi3L2
genes has been associated with inflammatory and degenerative
arthritis. Our data show that production of the chitinase-like pro-
teins forms part of the response to activation of TLRs both in
rat and human articular chondrocytes, indicating that, although
the receptor repertoire may be different, the outcome is very
similar. Expression of Chi3L2 in human articular chondrocytes
is more stringently controlled than that of Chi3L1 and requires
activation of the inflammatory signalling cascade. However, the
concomitant increase of Chi3L1 production indicates that there
is a degree of coordinate regulation of the two proteins in an
inflammatory milieu. Thus the expression of Chi3L2 in degen-
erate human articular cartilage indicates the activation of the
inflammatory signalling cascade, which may be responsible for
the tissue damage associated with this condition.
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Purpose: In this study we investigated the frequency and locality
of progenitor cells throughout AHAC via antibodies directed to-
wards Stro-1 and Notch-1. Moreover, to document chondrogenic
activities, we stained for Sox9, a specific transcription regulator
of collagen type II.
Methods: Paraffin embedded AHAC (collected under local ethi-
cal guidelines) from healthy (n=9) and OA affected (n=9) donors
were sectioned and immuno stained for detection of Notch-1
(Mouse IgG, Abcam), Stro-1 (Mouse IgM, R&D Systems) and
Sox9 (Rabbit IgG, Chemicon). Species matched IgG or IgM
were used as negative controls. Assessment of positive signal
localizations throughout each cartilage zone included systematic
counting of positive and negative cells in a 50Ã‘Âμm x 50Ã‘Âμm
grid (40x field), starting from the cartilage surface down to the
base of the collected tissue specimen. This was repeated five
times for each section. The identification of each zone was based
on previously reported characteristics that comprise cell shape,
morphology, orientation and pericellular matrix (PM) deposition
(3). The depth of each zone was recorded for each section for
comparative analysis on the frequency of positive signal in each
zone. Comparisons between each zone and between normal
and OA tissue were made via T-tests.
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Table 1. Positive signal (%) for Notch-1, Stro-1, and Sox9 in each zone of normal
and OA human cartilage.
Zone Normal OA
Notch-1 Superficial 61.2 ± 6.4a 70.1 ± 14.2a
Middle 31.3 ± 8.2b 58.7 ± 10.4a*
Deep 32.0 ± 7.3b 13.4 ± 6.5b*
Stro-1 Superficial 76.0 ± 9.3a 75.1 ± 5.2a
Middle 41.6 ± 7.9b 71.4 ± 7.0a*
Deep 13.0 ± 4.8c 40.9 ± 19.4a*
Sox9 Superficial 65.7 ± 5.8a 57.2 ± 11.2a
Middle 33.5 ± 9.1b 38.4 ± 5.4a
Deep 24.9 ± 7.0b 40.0 ± 12.7a
Results: In normal AHAC, over 60% of cells located within the
superficial zone (SZ) are positive for each molecule tested, while
signals decreased to approximately 40% in the middle zone
(MZ) and as much as 13% in the deep zone (DZ) (Table 1; letters
that are different are sig. different, P<0.05; asterisk denote sig.
change between normal and OA). Percent positive cells within
the SZ in OA tissue remain similar to normal. However, both
MZ and DZ staining patterns change in OA tissue. A significant
(P90%) in OA clusters are positive for Stro-1 and Notch-1.
Conclusions: These results indicate that SZ contain the highest
proportion of cells positive for the progenitor markers Stro-1
and Notch-1. Notch-1 staining frequency is comparable to that
reported in immature bovine cartilage. Differentiation potential
studies on the relatively high percentage of cells expressing
Notch-1 and Stro-1 are needed to test multilineage potential. The
unexpected observation that not all cells in articular cartilage
are Sox9 positive opens new questions on the role of this
transcription factor in differentiation of articular chondrocytes.
The high proportion of progenitor cells in the clusters present
in OA tissue may indicate a role of these cells in the abnormal
cell activation and differentiation processes that characterize OA
cartilage pathology.
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Purpose: We have previously demonstrated that there is an
FGF-2-dependent activation of ERK MAP kinase when articular
cartilage is cut or loaded, and that FGF-2 is sequestered in
the extracellular matrix, bound to heparan sulphate proteoglycan
(Vincent et al, 2002, 2004). We sought to determine to which
heparan sulphate proteoglycan FGF-2 was bound, where it was
in the matrix, and to confirm that it was the extracellular, rather
than intracellular, growth factor that mediated cell activation upon
cartilage loading. Finally we have investigated the role of FGF-2
on aggrecan degradation in human cartilage in vitro.
Methods: We purified perlecan and aggrecan from porcine ar-
ticular cartilage using a published method (Govindraj et al) and
used surface plasmon resonance (IASYS) to determine whether
either would bind immobilised recombinant FGF-2. Next we im-
munolocalised FGF-2, perlecan, beta 1 integrin, type VI collagen
in adult human articular cartilage, using conventional and confo-
cal microscopy.
To study the function of extracellular matrix FGF-2, we encapsu-
lated chondrocytes in alginate and allowed them to accumulate
matrix and FGF-2 over 3 weeks in culture. The concentration of
pericellular FGF-2 was adjusted by addition of exogenous growth
factor. Alginate encapsulated chondrocytes were embedded into
an alginate plug, and loaded cyclically for 2 minutes. After 30
mins cell lysates were immunoblotted for phosphorylated ERK.
To study the role of FGF-2 on proteoglycan degradation, hu-
man cartilage explants were stimulated for 24h with IL-1 in the
presence or absence of FGF-2. The conditioned medium was
analysed for GAG release (DMMB assay), and immunoblotted
for the aggrecanase neoepitope (anti-ARGS and anti-AGEG).
mRNA was extracted from the explants for PCR for ADAM-TS
4 and 5, and TIMP-3. In some experiments total tissue extracts
were generated for immunoblotting for ADAM-TS-5 protein.
Results: Using surface plasmon resonance, we found that FGF-2
bound to perlecan, but not to equimolar concentrations of ag-
grecan. This interaction was dependent upon heparan sulphate
as treatment with heparitinase abrogated binding. Perlecan and
FGF-2 co-localised within the type VI collagen-rich pericellular
matrix of articular chondrocytes. Alginate encapsulated chon-
drocytes accumulated pericellular perlecan and FGF-2 when
cultured in serum for 3 weeks, and an FGF-2 dependent acti-
vation of ERK occurred when these chondrocytes were loaded.
Loading induced activation of ERK was dependent upon the
concentration of pericellular matrix FGF-2.
On cartilage explants, FGF-2 was able to inhibit IL-1 mediated
GAG release and generation of the aggrecanase neoepitope.
FGF-2 suppressed ADAM-TS5 mRNA and protein, whilst having
no effect on ADAM-TS4, or TIMP-3.
Conclusions: FGF-2 is held in the pericellular matrix of artic-
ular cartilage and mediates chondrocyte activation upon tissue
loading. Our results suggest that FGF-2 is chondroprotective by
inhibiting expression and activity of ADAM-TS5, an important
IL-1 induced aggrecanase in human cartilage.
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Purpose: Cartilage tissue homeostasis is controlled by a balance
of anabolic and catabolic activities, induced by growth factors
and cytokines such as TGFb and IL-1. Chondrocytes respond to
anabolic TGFb by increasing matrix synthesis, while IL-1 elicits
a catabolic matrix degradation. Chondrocyte response to TGFb
is diminished with age, which may explain age as a leading risk
factor for osteoarthritis. The molecular mechanisms that underlie
the age-related diminished response are not fully understood.
We have shown increased stiffness in aging chondrocytes, con-
sistent with reports of altered actin cytoskeleton with age. The dy-
namic reorganization of the actin cytoskeleton influences signal
transduction pathways and cellular responses to growth factors,
and the converse is also true: growth factor stimulation alters
actin dynamics.
Actin dynamics are controlled by actin-binding proteins includ-
ing cofilin. Unphosphorylated cofilin destabilizes actin filaments.
Cofilin is inactivated by phosphorylation downstream of the Rho
Kinase (ROCK) pathway.
The purpose of this study is to determine whether anabolic
effects of TGFb require a dynamic reorganization of the actin
cytoskeleton mediated by the ROCK pathway and cofilin phos-
phorylation.
Methods: Chondrocytes were harvested from human articu-
lar cartilage by collagenase digestion and passaged once. For
matrix synthesis assays cells were embedded in 3% agarose
and precultured for 7-10 days. Cofilin phosphorylation assays
were done on monolayer cultures. Cells were serum-starved
24 hours, then treated with 5ng/ml TGFb and/or 10uM ROCK
